AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

VSee Health, Inc.

$0.01 -$0.41 (-97.61%)
OTC · 15 Sep 2026 14:17 UTC
Previous Close
$0.01
Day Range
$0.01$0.01
Year Range
$0.01$2.52
Market Cap
164.27K
AVG Volume
6.7M
Trailing/Forward PE
-0.02/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M2022202320242025
VSEE Revenue (USD) by year
PeriodRevenue (USD)
202514.62M
202410.42M
20235.77M
20226.38M
Net Income (USD)
-60M-40M-20M02022202320242025
VSEE Net Income (USD) by year
PeriodNet Income (USD)
2025-14.71M
2024-57.7M
2023-3.76M
2022-836.21K
Operating Income (USD)
-80M-60M-40M-20M02022202320242025
VSEE Operating Income (USD) by year
PeriodOperating Income (USD)
2025-9.58M
2024-62.15M
2023-1.87M
2022-1.68M
EBITDA (USD)
-10M-7.5M-5M-2.5M02.5M2022202320242025
VSEE EBITDA (USD) by year
PeriodEBITDA (USD)
2025-9.18M
2024-3.36M
2023-1.79M
2022134.79K
Cash Flows (USD)
-6M-4M-2M02022202320242025
VSEE Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-3.48M
2024-4.94M
2023-966.96K
2022-1.45M
EPS (USD)
-4-3-2-102022202320242025
VSEE EPS (USD) by year
PeriodEPS (USD)
2025-0.73
2024-3.85
2023-0.38
2022-0.08
Expenses (USD)
05M10M15M20MSG&ACapex2022202320242025
VSEE Expenses (USD) by year
PeriodExpenses (USD)
202515.65M
202411.92M
20233.57M
20226.3M
Cash & Debt (USD)
02.5M5M7.5M10MCashLong Term DebtShort Term Debt2022202320242025
VSEE Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20255.27M
2024326.12K
2023118.73K
2022230.66K
Debt ratios
00.511.52025
VSEE Debt ratios by year
PeriodDebt ratios
20250.2
Margins
0%20%40%60%80%2022202320242025
VSEE Margins by year
PeriodMargins
202550.32%
202468.87%
202366.47%
202275.81%
Return on Capital
-100000%0%100000%200000%300000%400000%2022202320242025
VSEE Return on Capital by year
PeriodReturn on Capital
2025-269.84%
2024312105.23%
202387.52%
202241131.58%
Shares Outstanding
010M20M30M2022202320242025
VSEE Shares Outstanding by year
PeriodShares Outstanding
202520.14M
202415.8M
202310M
202210M
Book Value Per Share (USD)
-0.6-0.4-0.2-00.20.42022202320242025
VSEE Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20250.27
2024-0
2023-0.43
2022-0
Total Assets (USD)
010M20M30M2022202320242025
VSEE Total Assets (USD) by year
PeriodTotal Assets (USD)
202522.41M
202419.99M
2023805.79K
20222.61M
Employee Count
010020030020242025
VSEE Employee Count by year
PeriodEmployee Count
2025209
2024154
Free Cash Flow Yield
-1000%-750%-500%-250%0%med -45.74%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VSEE Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-841.45%
Sep 26-785.35%
Sep 26-740.9%
Aug 26-736.27%
Aug 26-428.37%
Aug 26-400.69%
Aug 26-396.08%
Jul 26-145.95%
Jul 26-145.4%
Jul 26-118.42%
Jul 26-103.48%
Jul 26-104.42%
Jun 26-105.38%
Jun 26-99.36%
Jun 26-80.89%
Jun 26-72.24%
May 26-60.61%
May 26-71.7%
May 26-64.57%
May 26-95.86%
May 26-90.39%
Apr 26-81.2%
Apr 26-68.74%
Apr 26-74.95%
Apr 26-77.37%
Mar 26-113.84%
Mar 26-105.81%
Mar 26-97.58%
Mar 26-97.58%
Feb 26-74.04%
Feb 26-78.96%
Feb 26-78.28%
Feb 26-77.59%
Jan 26-75.68%
Jan 26-68.01%
Jan 26-62.23%
Jan 26-64.59%
Jan 26-64.77%
Dec 25-62.02%
Dec 25-61.95%
Dec 25-52.94%
Dec 25-49.77%
Nov 25-48.79%
Nov 25-45.83%
Nov 25-36.84%
Nov 25-24.81%
Oct 25-24.89%
Oct 25-39.01%
Oct 25-50.86%
Oct 25-45.64%
Oct 25-49%
Sep 25-49.23%
Sep 25-48.85%
Sep 25-44.85%
Sep 25-46.66%
Aug 25-52.1%
Aug 25-18.38%
Aug 25-19.28%
Aug 25-11.42%
Aug 25-12.46%
Jul 25-11.33%
Jul 25-11.17%
Jul 25-12.36%
Jul 25-12.88%
Jun 25-13.7%
Jun 25-13.83%
Jun 25-14.93%
Jun 25-13.22%
May 25-11.96%
May 25-13.83%
May 25-13.58%
May 25-12.88%
May 25-12.26%
Apr 25-11.87%
Apr 25-12.67%
Apr 25-14.36%
Apr 25-13.22%
Mar 25-13.46%
Mar 25-12.46%
Mar 25-11.87%
Mar 25-11.96%
Feb 25-9.98%
Feb 25-8.28%
Feb 25-8.06%
Feb 25-8.57%
Jan 25-8.97%
Jan 25-9.19%
Jan 25-10.26%
Jan 25-11.42%
Jan 25-11%
Dec 24-11%
Dec 24-11.25%
Dec 24-10.12%
Dec 24-9.42%
Nov 24-7.18%
Nov 24-10.19%
Nov 24-11.17%
Nov 24-30.64%
Nov 24-26.35%
Oct 24-20.69%
Price to Sales
01234med 0.97Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VSEE Price to Sales by year
PeriodPrice to Sales
Sep 260.06
Sep 260.06
Sep 260.07
Aug 260.07
Aug 260.12
Aug 260.12
Aug 260.1
Jul 260.26
Jul 260.26
Jul 260.32
Jul 260.37
Jul 260.36
Jun 260.36
Jun 260.38
Jun 260.47
Jun 260.53
May 260.63
May 260.53
May 260.59
May 260.25
May 260.26
Apr 260.29
Apr 260.35
Apr 260.32
Apr 260.31
Mar 260.27
Mar 260.29
Mar 260.32
Mar 260.32
Feb 260.42
Feb 260.39
Feb 260.4
Feb 260.4
Jan 260.41
Jan 260.46
Jan 260.5
Jan 260.48
Jan 260.48
Dec 250.5
Dec 250.5
Dec 250.59
Dec 250.62
Nov 250.64
Nov 250.68
Nov 250.84
Nov 251.15
Oct 251.15
Oct 250.73
Oct 250.56
Oct 251.04
Oct 250.97
Sep 250.96
Sep 250.97
Sep 251.06
Sep 251.02
Aug 250.91
Aug 251.55
Aug 251.48
Aug 252.49
Aug 252.28
Jul 252.51
Jul 252.55
Jul 252.3
Jul 252.21
Jun 252.08
Jun 252.06
Jun 251.91
Jun 252.15
May 252.38
May 252.06
May 252.09
May 252.21
May 252.32
Apr 252.4
Apr 252.25
Apr 251.98
Apr 252.15
Mar 252.11
Mar 252.28
Mar 252.4
Mar 252.38
Feb 252.85
Feb 253.43
Feb 253.53
Feb 253.32
Jan 253.17
Jan 253.09
Jan 252.77
Jan 252.49
Jan 252.59
Dec 242.59
Dec 242.53
Dec 242.81
Dec 243.02
Nov 243.96
Nov 242.79
Nov 242.55
Nov 241.12
Nov 241.31
Oct 241.66
Price to Book
02468med 3.45Nov 24Jan 25Apr 25Jun 25Apr 26Jul 26Sep 26
VSEE Price to Book by year
PeriodPrice to Book
Sep 260.1
Sep 260.11
Sep 260.11
Aug 260.11
Aug 260.19
Aug 260.21
Aug 260.22
Jul 260.6
Jul 260.6
Jul 260.74
Jul 260.84
Jul 260.83
Jun 260.83
Jun 260.88
Jun 261.08
Jun 261.2
May 261.44
May 261.21
May 261.35
May 260.66
May 260.71
Apr 260.79
Apr 260.93
Apr 260.85
Apr 260.82
Aug 252.6
Aug 252.48
Aug 254.18
Aug 253.83
Jul 254.21
Jul 254.28
Jul 253.87
Jul 253.71
Jun 253.49
Jun 253.45
Jun 253.2
Jun 253.61
May 253.99
May 253.45
May 253.52
May 253.71
May 253.9
Apr 254.02
Apr 253.77
Apr 253.33
Apr 253.61
Mar 253.55
Mar 253.83
Mar 254.02
Mar 253.99
Feb 254.78
Feb 255.77
Feb 255.92
Feb 255.58
Jan 255.32
Jan 255.2
Jan 254.66
Jan 254.18
Jan 254.34
Dec 244.34
Dec 244.25
Dec 244.72
Dec 245.07
Nov 246.65
Nov 244.69
Nov 244.28
Nov 240.12
Nov 240.15
Oct 240.18
Oct 240.16
Oct 240.11
Oct 240.12
Sep 240.14
VSee Health, Inc.
VSEE
Stockpicker

Video analysis: VSEE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VSEE

VSee Health Poised for Growth

accessnewswire.com · 27 Aug 2026

VSee Health Poised for Growth

VSee Health announces Annual Meeting Results HOUSTON, TX / ACCESS Newswire / August 27, 2026 / VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has identified approximately $1 million in near term annual savings associated with its transition from Nasdaq, the reduction of public-company expenses and the streamlining of its corporate operations. The Company intends to redirect these savings toward revenue-generating growth initiatives, working capital and the continued expansion of its hospital-based telehealth operations.

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

accessnewswire.com · 30 Jul 2026

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

The acquisition is expected to close fairly quickly and without any initial shareholder dilution HOUSTON, TX / ACCESS Newswire / July 30, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market.

VSEE Vertically Integrated Healthcare Commerce Platform

accessnewswire.com · 29 Jul 2026

VSEE Vertically Integrated Healthcare Commerce Platform

Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings HOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market.

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

accessnewswire.com · 28 Jul 2026

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value. The Board believes VSee has reached an important inflection point.

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

accessnewswire.com · 22 Jul 2026

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals.

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

accessnewswire.com · 14 Jul 2026

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. "We believe healthcare is entering a new technology cycle in which artificial intelligence becomes an operating layer, rather than simply another application," said Dr. Imoigele Aisiku, Chairman and Chief Executive Officer of VSee Health.

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

accessnewswire.com · 9 Jul 2026

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook. Dear Fellow Shareholders, Over the past two years, VSee Health has undergone a significant transformation.

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

accessnewswire.com · 25 Jun 2026

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.